Precision BioSciences DTIL reported its Q2 earnings results on Monday, August 8, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Precision BioSciences missed estimated earnings by 12.2%, reporting an EPS of $-0.46 versus an estimate of $-0.41.
Revenue was down $64.98 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 6.29% increase in the share price the next day.
Here's a look at Precision BioSciences's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.55 | -0.47 | -0.59 | -0.44 |
| EPS Actual | -0.46 | -0.52 | -0.19 | 0.36 |
| Revenue Estimate | 6.63M | 7.75M | 6.02M | 13.86M |
| Revenue Actual | 3.32M | 6.34M | 24.04M | 68.81M |
To track all earnings releases for Precision BioSciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
